Cleared Traditional

K151678 - Chameleon PTA Balloon Catheter

K151678 is an FDA 510(k) clearance for Chameleon PTA Balloon Catheter, manufactured by Av Medical Technologies, Ltd.. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K151678 · Av Medical Technologies, Ltd. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2015
Decision
91d
Days
Class 2
Risk

K151678 is an FDA 510(k) clearance for the Chameleon PTA Balloon Catheter. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Av Medical Technologies, Ltd. (Tel-Aviv, IL). The FDA issued a Cleared decision on September 21, 2015 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K151678

510(k) Number K151678 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 22, 2015
Decision Date September 21, 2015
Days to Decision 91 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 125d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Dohmen Life Science Services, LLC
Ian Marsden

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 381
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K151678.
Passeo-18 Peripheral Dilation Catheter
K151744 · Biotronik, Inc. · Oct 2015
Passeo-14 Peripheral Dilatation Catheter
K152240 · Biotronik, Inc. · Oct 2015
Metacross OTW PTA Balloon Dilatation Catheter
K152080 · KANEKA Corporation · Sep 2015
Ebony PTA .014 RX Pheripheral Dilatation Catheter
K152230 · Natec Medical · Sep 2015
Pirouette 018
K151153 · Arravasc Limited · Aug 2015
ComboCath OTW PTA Dilatation Catheter
K150452 · Summa Therapeutics, LLC · Aug 2015